Characterisation of carotid plaques with ultrasound elastography: feasibility and correlation with high-resolution magnetic resonance imaging

[1] Rothwell PM(2003)Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis Lancet 361 107-116

[2] Eliasziw M(2010)10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial Lancet 376 1074-1084

[3] Gutnikov SA(2003)From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I Circulation 108 1664-1672

[4] Halliday A(2006)Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the oxford plaque study Circulation 113 2320-2328

[5] Harrison M(2006)In vivo characterization and quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation Arterioscler Thromb Vasc Biol 26 2366-2372

[6] Hayter E(2006)In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 1818-1824

[7] Naghavi M(2003)Texture-based classification of atherosclerotic carotid plaques IEEE Trans Med Imaging 22 902-912

[8] Libby P(2005)3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies Stroke 36 1904-1909

[9] Falk E(2005)In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology Circulation 112 3437-3444

[10] Redgrave JNE(2005)Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience Radiology 234 487-492

[1] Rothwell PM(2003)Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis Lancet 361 107-116

[2] Eliasziw M(2010)10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial Lancet 376 1074-1084

[3] Gutnikov SA(2003)From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I Circulation 108 1664-1672

[4] Halliday A(2006)Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the oxford plaque study Circulation 113 2320-2328

[5] Harrison M(2006)In vivo characterization and quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation Arterioscler Thromb Vasc Biol 26 2366-2372

[6] Hayter E(2006)In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 1818-1824

[7] Naghavi M(2003)Texture-based classification of atherosclerotic carotid plaques IEEE Trans Med Imaging 22 902-912

[8] Libby P(2005)3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies Stroke 36 1904-1909

[9] Falk E(2005)In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology Circulation 112 3437-3444

[10] Redgrave JNE(2005)Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience Radiology 234 487-492